Immuneel's CAR-T cell therapy reports positive in early phase-2 trials in India

The early results from the IMAGINE study were based on the first 10 patients of the planned 24 patients to be enrolled.Both adult and children with acute leukemia as well as lymphoma patients post median 2 lines of treatment, including in post-transplant settings were enrolled.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/cFYLsTo
via IFTTT